Germ Cell Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Germ Cell
| Protocol | Alliance A031102 |
|---|---|
| Cancer Type: | Germ Cell Tumor |
| Fast Facts |
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG AGCT1531 |
|---|---|
| Cancer Type: | Germ Cell |
| Fast Facts |
A Phase III Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
Age:
- Low Risk Stratum (Stage I Ovarian Immature Teratoma and Stage I Malignant GCT (all sites))
Patients must be < 50 Years of Age at Enrollment. - Standard Risk 1
Patient must be < 11 Years of Age at Enrollment. - Standard Risk 2
Patients must be ≥ 11 and < 25 Years of Age at Enrollment.
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1823 |
|---|---|
| Cancer Type: | Newly Diagnosed Germ Cell Tumors |
| Fast Facts |
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG AGCT1532 |
|---|---|
| Cancer Type: | Germ Cell |
| Fast Facts |
Phase III Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Age ≥ 11 Years and ≤ 45 Years on the Date of Randomization
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
